{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:32:09Z","timestamp":1789378329904,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.parkreldis.2006.02.004","type":"journal-article","created":{"date-parts":[[2006,6,12]],"date-time":"2006-06-12T16:49:43Z","timestamp":1150130983000},"page":"506-508","source":"Crossref","is-referenced-by-count":32,"title":["Dopamine agonist therapy for Parkinson disease and pathological gambling"],"prefix":"10.1016","volume":"12","author":[{"given":"Akiko","family":"Imamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Uitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew K.","family":"Wszolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2006.02.004_bib1","first-page":"115","article-title":"Parkinson's disease: drug-induced psychiatric states","volume":"65","author":"Factor","year":"1995","journal-title":"Adv Neurol"},{"key":"10.1016\/j.parkreldis.2006.02.004_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/1520-6394(2000)11:4<185::AID-DA8>3.0.CO;2-H","article-title":"Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents","volume":"11","author":"Seedat","year":"2000","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.parkreldis.2006.02.004_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I","article-title":"Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?","volume":"15","author":"Molina","year":"2000","journal-title":"Movement Disord"},{"key":"10.1016\/j.parkreldis.2006.02.004_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/mds.10625","article-title":"Disabling repetitive behaviors in Parkinson's disease","volume":"19","author":"Kurlan","year":"2004","journal-title":"Movement Disord"},{"key":"10.1016\/j.parkreldis.2006.02.004_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00002826-200105000-00009","article-title":"Pathologic gambling in patients with Parkinson's disease","volume":"24","author":"Gschwandtner","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.parkreldis.2006.02.004_bib6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1212\/01.WNL.0000076478.45005.EC","article-title":"Pathological gambling associated with dopamine agonist therapy in Parkinson's disease","volume":"61","author":"Driver-Dunckley","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2006.02.004_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10072-004-0238-z","article-title":"Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease","volume":"25","author":"Avanzi","year":"2004","journal-title":"Neurol Sci"},{"key":"10.1016\/j.parkreldis.2006.02.004_bib8","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2006.02.004_bib9","series-title":"Diagnostic and statistical manual of mental disorders: DSM-IV-TR\u2122","year":"2000"},{"key":"10.1016\/j.parkreldis.2006.02.004_bib10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-003-0027-5","article-title":"Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum","volume":"110","author":"Gerlach","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.parkreldis.2006.02.004_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2006.02.004_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nn1378","article-title":"Pathological gambling is linked to reduced activation of the mesolimbic reward system","volume":"8","author":"Reuter","year":"2005","journal-title":"Nat Neurosci"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802006000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802006000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T16:25:47Z","timestamp":1547569547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802006000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S1353802006000368"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2006.02.004","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}